Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of “Hold” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has earned an average recommendation of “Hold” from the nine analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $21.56.

Separately, Jefferies Financial Group initiated coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company.

Oscar Health Price Performance

OSCR stock opened at $15.99 on Monday. The business’s 50-day moving average is $15.17 and its two-hundred day moving average is $16.50. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $4.01 billion, a P/E ratio of -799.25 and a beta of 1.75. Oscar Health has a 1 year low of $12.43 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Analysts anticipate that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of OSCR. Vanguard Group Inc. boosted its stake in Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock valued at $255,333,000 after acquiring an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its holdings in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. Thrive Capital Management LLC boosted its position in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, Gilder Gagnon Howe & Co. LLC grew its stake in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after buying an additional 2,151,256 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.